ArticleBreast cancer research : BCR2025

Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models.

Seungyeon Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.